Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 540

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 540
---
 Amended Note of $0.2 million.

<div align='center'>F-85</div>

TABLE OF CONTENTS

#### Annex A​

### BUSINESS COMBINATION AGREEMENT
<div align='center'>by and among</div>

#### IRIS ACQUISITION CORP,

#### IRIS PARENT HOLDING CORP.,

#### SPAC MERGER SUB, INC.,

#### LIMINATUS PHARMA MERGER SUB, INC.
<div align='center'>and</div>

#### LIMINATUS PHARMA, LLC

#### DATED AS OF NOVEMBER 30, 2022
TABLE OF CONTENTS

Table of Contents

| ​ | ARTICLE I CERTAIN DEFINITIONS                                                             | ​ | ​ | ​ | ​ | A-2  | ​ | ​ |
| ​ | Section 1.1                                                                               
 Certain Definitions                                                                       
 ​                                                                                         | ​ | ​ | ​ | ​ | A-2  | ​ | ​ |
| ​ | ARTICLE II MERGERS                                                                        | ​ | ​ | ​ | ​ | A-15 | ​ | ​ |
| ​ | Section 2.1                                                                               
 Company Merger                                                                            
 ​                                                                                         | ​ | ​ | ​ | ​ | A-15 | ​ | ​ |
| ​ | Section 2.2                                                                               
 SPAC Merger                                                                               
 ​                                                                                         | ​ | ​ | ​ | ​ | A-15 | ​ | ​ |
| ​ | Section 2.3                                                                               
 Closing; Effective Time                                                                   
 ​                                                                                         | ​ | ​ | ​ | ​ | A-15 | ​ | ​ |
| ​ | Section 2.4                                                                               
 Effect of the Mergers                                                                     
 ​                                                                                         | ​ | ​ | ​ | ​ | A-16 | ​ | ​ |
| ​ | Section 2.5                                                                               
 Governing Documents                                                                       
 ​                                                                                         | ​ | ​ | ​ | ​ | A-16 | ​ | ​ |
| ​ | Section 2.6                                                                               
 Taking of Necessary Action; Further Action                                                
 ​                                                                                         | ​ | ​ | ​ | ​ | A-16 | ​ | ​ |
| ​ | ARTICLE III CONSIDERATION                                                                 | ​ | ​ | ​ | ​ | A-16 | ​ | ​ |
| ​ | Section 3.1                                                                               
 Company Merger Consideration                                                              
 ​                                                                                         | ​ | ​ | ​ | ​ | A-16 | ​ | ​ |
| ​ |